Insider · CIK 0001076341
Richard A Barasch
director
Files at STLN (Oncology Institute, Inc.). First filing Mar 28, 2025, latest Mar 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1.4M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 65Notable | buy 5 | STLN Oncology Institute, Inc. | $1.4M | 1,358,448 | +326% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stockindirect: By LLC | +1,358,448 | $1.04 | $1.4M | 1,775,641 | Mar 28, 2025 |
| Mar 26, 2025 | STLN Oncology Institute, Inc. | POpen-market purchase Common Warrantderivativeindirect: By LLC | +679,224 | $0.13 | $85k | 679,224 | Mar 28, 2025 |
| Nov 22, 2024 | STLN Oncology Institute, Inc. | AGrant or award Common stock | +80,000 | $0.00 | $0 | 417,193 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.